Archive
60 seconds with…Maja Andreevska, R&D Finance Business Partner
News published on April 27, 2026
Recently we spoke with Maja Andreevska, R&D Finance Business Partner at Oxford Health.
Do you know about the OPEN-ARMS clinic?
News published on April 23, 2026
OPEN-ARMS is the specialist early psychosis prevention clinic within Oxford Health NHS Foundation Trust (OHFT), supporting young people aged 14–35.
Driving real change: parliamentary recognition for NHS innovation adoption
News published on April 17, 2026
Congratulations to Nnenna Omeje, nominated for the Parliamentary Pathfinder NHS Innovation Adoption Awards 2026
Latest updates from NIHR Biomedical Research Centre: Oxford Health
News published on April 15, 2026
April’s newsletter brings you a new roundup of updates, research highlights, and news from us and our partners at our Biomedical Research Centre.
Join our Clinical Research team
News published on April 14, 2026
Could You Be Part of Our Team? A specialist Clinical Research Role at the heart of Oxford Health Clinical Research Facility
Welcome Professor Jeremy Hall
News published on April 7, 2026
Professor Jeremy Hall has been appointed Deputy Director of NIHR Biomedical Research Centre: Oxford Health
NHS Oxford Health expecting low impact to patient services during planned industrial action
News published on April 2, 2026
Oxford Health NHS Foundation Trust expects well-established continuity plans will minimise impact to patient services during planned industrial action next week.
New Chair takes up role at Oxford Health
News published on April 1, 2026
Andrea Young has officially become Chair of Oxford Health NHS Foundation Trust.
Could research help you?
News published on March 30, 2026
World Bipolar Day provides an opportunity to highlight our specialist Bipolar research clinic at Oxford Health NHS FT (OHFT) which is helping to improve understanding, treatment and care for people living with Bipolar disorder.
Could you take part in Alzheimer’s research?
News published on March 26, 2026
Research opportunities to trial disease‑modifying therapies for Alzheimer’s disease are open for recruitment